Search Results

Filter
  • 1-10 of  84,673 results for ""ANTI-HIV agents""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Intracellular islatravir-triphosphate half-life supports extended dosing intervals.

  • Authors : Zang X; Merck & Co., Inc., Rahway, New Jersey, USA.; Ankrom W

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/pharmacokinetics ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/administration & dosage

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Sep 04; Vol. 68 (9), pp. e0045824. Date of Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection.

  • Authors : Bae J; Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA.; Tantawy M

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/genetics ; Lamivudine*/Lamivudine*/Lamivudine*/therapeutic use

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Sep 04; Vol. 68 (9), pp. e0054924. Date of Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study.

  • Authors : Ugarte A; HIV Unit, Infectious Diseases Service, Hospital Clinic of Barcelona, Villarroel Street 170, Barcelona 08036, Spain.; University of Barcelona, Barcelona, Spain.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Sep 03; Vol. 79 (9), pp. 2343-2353.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Low CD4 counts predict excessive weight gains during first-line treatment for HIV.

  • Authors : Hill A; University of Liverpool, Department of Pharmacology and Therapeutics, 70 Pembroke Place, Liverpool L69 3GF, Liverpool, UK.; Tovar Sanchez T

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Weight Gain*/Weight Gain*/Weight Gain*/drug effects ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Sep 03; Vol. 79 (9), pp. 2369-2378.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Breakthrough HIV viraemia on bictegravir/emtricitabine/tenofovir alafenamide in the third trimester of pregnancy.

  • Authors : Miller C; Infectious Diseases, The Ottawa Hospital, Ottawa, ON, Canada.; Giguère P

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Emtricitabine*/Emtricitabine*/Emtricitabine*/therapeutic use ; Emtricitabine*/Emtricitabine*/Emtricitabine*/administration & dosage

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Sep 03; Vol. 79 (9), pp. 2390-2391.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; Viral Load*/Viral Load*/Viral Load*/drug effects

  • Source: The lancet. HIV [Lancet HIV] 2024 Sep; Vol. 11 (9), pp. e576-e585.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print Cited Medium: Internet ISSN: 2352-3018

Record details

×
Academic Journal

US cost-utility model of lenacapavir plus optimized background regimen (OBR) vs fostemsavir plus OBR and ibalizumab plus OBR for people with HIV with multidrug resistance.

Subjects: Cost-Benefit Analysis* ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/economics

  • Source: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Sep; Vol. 30 (9), pp. 1001-1012.Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study.

  • Authors : Rael CT; Christine Tagliaferri Rael, PhD, is an Assistant Professor in the University of Colorado College of Nursing, Aurora, Colorado, USA. Doyel Das, BS, is an MPH Student in the Columbia University Mailman School of Public Health, New York, New York, USA. Jonathan Porter, MPH, was an MPH Student in the Columbia University Mailman School of Public Health, New York, New York, USA, and a Professional Research Assistant in the University of Colorado College of Nursing, Aurora, Colorado, USA. He is currently a Research Consultant, Optem Serve Consulting/The Lewin Group, New York, New York, USA. Javier Lopez-Ríos, PhD, MPH is an Assistant Professor in the Dornsife School of Public Health at Drexel University, Philadelphia, Philadelphia, USA. Elena Abascal, DNP, NP, was a DNP student at the Columbia University School of Nursing, New York, New York, USA, and a Clinical Research Nurse at the New York State Psychiatric Institute (NYSPI), New York, New York, USA. She is currently a Nurse Practitioner, Columbia University Irving Medical Center/New York Presbyterian Morgan Stanley Children's Hospital, New York, New York, USA. Curtis Dolezal, PhD is an Assistant Clinical Professor in the HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute/Columbia University Psychiatry, New York, New York, USA. Michael P. Vaughn, PhD, MPH was a Postdoctoral Research Fellow in the HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute/Columbia University Psychiatry, New York, New York, USA. He is currently the Research Operations Lead (Experience Design), Capital One Bank, New York, New York, USA. Pilar Giffenig, DNP, MSN, APRN, FNP-C, was a DNP student at the Columbia University School of Nursing, New York, New York, USA, and a Clinical Research Nurse at the New York State Psychiatric Institute, New York, New York, USA. She is currently a Nurse Practitioner, RemoteFocus, New York, New York, USA. Jasmine M. Lopez, BS, is a Research Assistant in the HIV Center for Clinical and Behavioral Studies at NYSPI/Columbia University Psychiatry, New York, New York, USA. Samantha Stonbraker, PhD, MPH, RN, is an Assistant Professor in the University of Colorado College of Nursing, Aurora, Colorado, USA. Christina Sun, PhD, is an Associate Professor in the University of Colorado Collee of Nursing, Aurora, Colorado, USA. Roque Anthony Velasco, MS, NP, is a PhD Student in the University of Colorado College of Nursing, Aurora, Colorado, USA. Leandra Bitterfeld, RN, is a PhD Student in the University of Colorado College of Nursing, Aurora, CO, USA. Walter O. Bockting, PhD, is a Professor and Co-Chief of the Gender Health and Sexuality Area at New York State Psychiatric Institute/Columbia University, New York, New York, USA, and a Professor in the Columbia University School of Nursing, New York, New York, USA. Jose Bauermeister, PhD, MPH, FSBM, is a Professor in the School of Nursing and School of Medicine and the Albert M Greenfield University Professor of Human Relations at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Das D

Subjects: Transgender Persons*/Transgender Persons*/Transgender Persons*/psychology ; Transgender Persons*/Transgender Persons*/Transgender Persons*/statistics & numerical data ; Qualitative Research*

  • Source: The Journal of the Association of Nurses in AIDS Care : JANAC [J Assoc Nurses AIDS Care] 2024 Sep-Oct 01; Vol. 35 (5), pp. 437-449. Date of Electronic Publication: 2024 Aug 13.Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 9111870 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Impact of financial incentives on viral suppression among adults initiating HIV treatment in Tanzania: a hybrid effectiveness-implementation trial.

  • Authors : Njau PF; National AIDS, STIs and Hepatitis Control Programme, Ministry of Health, Dodoma, Tanzania.; Katabaro E

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; Viral Load*/Viral Load*/Viral Load*/drug effects

  • Source: The lancet. HIV [Lancet HIV] 2024 Sep; Vol. 11 (9), pp. e586-e597. Date of Electronic Publication: 2024 Aug 01.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Current status of the small molecule anti-HIV drugs in the pipeline or recently approved.

  • Authors : Umumararungu T; Department of Industrial Pharmacy, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Rwanda. Electronic address: .; Nyandwi JB

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/pharmacology ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/chemistry ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/chemical synthesis

  • Source: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2024 Sep 01; Vol. 111, pp. 117860. Date of Electronic Publication: 2024 Jul 29.Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  84,673 results for ""ANTI-HIV agents""